Metronomic chemotherapy in pediatric oncology: from preclinical evidence to clinical studies
Metronomic chemotherapy (MC) is the frequent, regular administration of drug doses
designed to maintain a low, but active, range of concentrations of chemotherapeutic drugs …
designed to maintain a low, but active, range of concentrations of chemotherapeutic drugs …
Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma
SW Chou, HH Chang - Cancer Letters, 2024 - Elsevier
Metronomic chemotherapy refers to the consistent and regular administration of low-dose
chemotherapeutic agents over an extended period, with minimal or no extended drug-free …
chemotherapeutic agents over an extended period, with minimal or no extended drug-free …
[HTML][HTML] Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in gastric cancer xenograft model
Z Ghazvinian, S Abdolahi, M Ahmadvand… - BioImpacts …, 2023 - ncbi.nlm.nih.gov
Chemo-immune cell therapy by intratumoral injection of adoptive NK cells with capecitabine in
gastric cancer xenograft model - PMC Back to Top Skip to main content NIH NLM Logo Access …
gastric cancer xenograft model - PMC Back to Top Skip to main content NIH NLM Logo Access …
Oral metronomic chemotherapy is a cost effective alternative to pazopanib in advanced soft tissue sarcoma
Introduction Soft tissue sarcoma (STS) is a rare and heterogeneous group of disorders with
dismal outcomes in metastatic setting. Pazopanib and oral metronomic chemotherapy (OMT) …
dismal outcomes in metastatic setting. Pazopanib and oral metronomic chemotherapy (OMT) …
Quality of life in paediatric solid tumours: A randomised study of metronomic chemotherapy versus placebo
R Pramanik, S Agarwala, V Sreenivas… - BMJ Supportive & …, 2023 - spcare.bmj.com
Objective Health-related quality of life (HRQoL) is an important outcome for paediatric
cancer studies. We compared the HRQoL between patients of progressive paediatric solid …
cancer studies. We compared the HRQoL between patients of progressive paediatric solid …
[HTML][HTML] Metronomics in Pediatric Oncology: Lessons Learned and the Way Forward
PS Kulkarni, K Das, N Agrawal, M Kala, R Khanduri… - ijmpo.org
Metronomic chemotherapy appeared as a new “genre” of chemotherapy from the bench to
bedside in the early 2000s and since then has secured a niche for itself in oncology practice …
bedside in the early 2000s and since then has secured a niche for itself in oncology practice …
Metronomics in pediatric oncology: Lessons learned and the way forward
R Pramanik, S Bakhshi - Indian Journal of Medical and …, 2020 - thieme-connect.com
On critically examining the current metronomic literature in pediatric oncology, one finds that
there are very limited Phase 1 and 2 data. Most studies have recorded a clinical benefit in …
there are very limited Phase 1 and 2 data. Most studies have recorded a clinical benefit in …
[PDF][PDF] Slow and Steady Keeps Them in the Race: Metronomic Therapy in Children With Cancer
S Totadri - Oncol, 2019 - indianpediatrics.net
(HIC)[1]. This success story is attributable to advances in diagnosis and risk stratification,
and the protocolized administration of cytotoxic therapy [1, 2]. However, the survival lags by …
and the protocolized administration of cytotoxic therapy [1, 2]. However, the survival lags by …
[PDF][PDF] Platelet Normalized Serum Vascular Endothelial Growth Factor Levels in Progressive Pediatric Solid Malignancies
A Batra - Clin Sci, 1998 - indianpediatrics.net
We read with interest the recently published article by Pramanik, et al.[1]. The study reported
inconsistent trends in serum vascular endothelial growth factor (VEGF) and thrombospondin …
inconsistent trends in serum vascular endothelial growth factor (VEGF) and thrombospondin …
[引用][C] Platelet Normalized Serum Vascular Endothelial Growth Factor Levels in Progressive Pediatric Solid Malignancies: Authors' Reply.
R Pramanik, S Bakhshi - Indian Pediatrics, 2020 - europepmc.org
We read with interest the recently published article by Pramanik, et al.[1]. The study reported
inconsistent trends in serum vascular endothelial growth factor (VEGF) and thrombospondin …
inconsistent trends in serum vascular endothelial growth factor (VEGF) and thrombospondin …